Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126606982 | 12660698 | 2 | F | 201605 | 20160616 | 20160817 | 20160901 | EXP | US-RELYPSA-RLY2016001086 | RELYPSA | 73.51 | YR | M | Y | 0.00000 | 20160901 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126606982 | 12660698 | 1 | PS | VELTASSA | PATIROMER | 1 | Oral | 8.4 G, QD | 0 | 8.4 | G | ORAL SUSPENSION | |||||||
| 126606982 | 12660698 | 2 | C | CLONIDINE HCL | CLONIDINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126606982 | 12660698 | 3 | C | ENALAPRIL MALEATE. | ENALAPRIL MALEATE | 1 | 0 | ||||||||||||
| 126606982 | 12660698 | 4 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 126606982 | 12660698 | 5 | SS | HYDRALAZINE HCL | HYDRALAZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126606982 | 12660698 | 6 | C | MAGNESIUM | MAGNESIUM | 1 | 0 | ||||||||||||
| 126606982 | 12660698 | 7 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | 0 | ||||||||||||
| 126606982 | 12660698 | 8 | C | NIFEDICAL XL | NIFEDIPINE | 1 | 0 | ||||||||||||
| 126606982 | 12660698 | 9 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
| 126606982 | 12660698 | 10 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | 0 | ||||||||||||
| 126606982 | 12660698 | 11 | C | VITAMIN A /00056001/ | RETINOL | 1 | 0 | ||||||||||||
| 126606982 | 12660698 | 12 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | 0 | ||||||||||||
| 126606982 | 12660698 | 13 | C | VITAMIN C | ASCORBIC ACID | 1 | 0 | ||||||||||||
| 126606982 | 12660698 | 14 | C | ZINC | ZINCINC CHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126606982 | 12660698 | 1 | Hyperkalaemia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126606982 | 12660698 | Constipation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126606982 | 12660698 | 1 | 20160512 | 0 |